E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers M > Headlines for MedImpact Holdings, Inc. > News item
Published on 9/28/2015 in the Prospect News Bank Loan Daily.

MedImpact sets Wednesday meeting for $350 million first-lien term loan

By Paul A. Harris

Portland, Ore., Sept. 28 – A bank meeting for MedImpact's $350 million seven-year first-lien term loan B is set for 10:30 a.m. ET on Wednesday, according to a market source.

UBS Investment Bank is the bookrunner.

The loan price and spread remain to be determined.

The interest rate will float atop a 1% Libor floor.

The borrower is a San Diego-based full-service pharmacy benefit management company.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.